Keeley-Teton Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $609K | Buy |
18,598
+4,961
| +36% | +$162K | 0.07% | 267 |
|
|
2024
Q4 | $493K | Sell |
13,637
-2,163
| -14% | -$78.2K | 0.06% | 291 |
|
|
2024
Q3 | $493K | Hold |
15,800
| – | – | 0.05% | 308 |
|
|
2024
Q2 | $423K | Hold |
15,800
| – | – | 0.05% | 293 |
|
|
2024
Q1 | $539K | Hold |
15,800
| – | – | 0.07% | 272 |
|
|
2023
Q4 | $457K | Hold |
15,800
| – | – | 0.06% | 285 |
|
|
2023
Q3 | $436K | Hold |
15,800
| – | – | 0.06% | 276 |
|
|
2023
Q2 | $475K | Hold |
15,800
| – | – | 0.06% | 284 |
|
|
2023
Q1 | $572K | Buy |
15,800
+1,400
| +10% | +$50.7K | 0.07% | 276 |
|
|
2022
Q4 | $514K | Buy |
14,400
+3,400
| +31% | +$121K | 0.06% | 289 |
|
|
2022
Q3 | $372K | Hold |
11,000
| – | – | 0.05% | 304 |
|
|
2022
Q2 | $318K | Hold |
11,000
| – | – | 0.04% | 330 |
|
|
2022
Q1 | $356K | Buy |
+11,000
| New | +$356K | 0.04% | 336 |
|